Pull to refresh
Logo
Centers for Medicare & Medicaid Services

Centers for Medicare & Medicaid Services

Federal agency

Appears in 12 stories

Stories

Aroa Biosurgery trial shows Symphony heals diabetic foot ulcers faster

New Capabilities

Reclassified most CAMPs effective January 1, 2026

Aroa Biosurgery published results from a randomized controlled trial showing its Symphony wound dressing heals diabetic foot ulcers faster than standard care. The study, in the International Wound Journal, found 55% of ulcers closed within 12 weeks with Symphony, versus 35% with standard care alone.

Updated Yesterday

HHS launches vaccine injury research and reporting initiative

Rule Changes

Proposing first-ever physician reimbursement for VAERS reporting

The federal government opened a dedicated clinic at the National Institutes of Health this month to study and treat people reporting health problems after vaccination. It's the centerpiece of a new agency-wide push by the Department of Health and Human Services (HHS) to document, investigate, and respond to vaccine injuries. An internal memo obtained by NPR says NIH plans an observational study of vaccinated people and possible complications, and may examine vaccine schedules and treatments.

Updated 2 days ago

HHS finalizes overhaul of health insurance price transparency rules

Rule Changes

Administers the Transparency in Coverage rules

Health insurers must now publish their negotiated rates in a form that researchers and consumers can actually use. The Department of Health and Human Services (HHS) finalized updates to the Transparency in Coverage rules on October 5, 2026, with the Departments of Labor and the Treasury.

Updated 6 days ago

Bayesian Health's continuous AI sepsis monitor wins Medicare add-on payment

Rule Changes

Approved NTAP for Bayesian's sepsis monitor in FY 2027 Final Rule

Since October 1, 2026, hospitals using Bayesian Health's continuous AI sepsis monitor can bill Medicare for an extra payment of up to $61.84 per eligible discharge. The Centers for Medicare and Medicaid Services (CMS) approved the add-on payment in its FY 2027 Inpatient Prospective Payment System Final Rule.

Updated 6 days ago

Medicare adds PearlMatrix bone graft to new-technology payment program

Rule Changes

Granted NTAP designation to PearlMatrix, effective October 1, 2026

Hospitals that use PearlMatrix, a peptide-enhanced bone graft proven to speed lumbar fusion, can now claim up to 65% of its added cost back from Medicare. The Centers for Medicare & Medicaid Services (CMS) granted the graft New Technology Add-on Payment (NTAP) status, effective October 1, 2026.

Updated Oct 2

Trump administration cancels ACA coverage for hundreds of thousands over fraud claims

Rule Changes

Carried out Aug. 31 cancellations; interim final rule published Sept. 23

On Aug. 31, CMS canceled 315,000 ACA marketplace policies covering 760,000 people, citing suspected fraud. The White House made the move public Sept. 22, saying brokers enrolled many without their knowledge and some enrollees may not exist.

Updated Sep 29

RadiantGraph launches AI care agents under Medicare's outcomes-based ACCESS model

New Capabilities

Administers the ACCESS Model, Medicare, and Medicaid

Half of people with chronic conditions skip their treatment plans, and health plans have never closed that gap at scale. On September 16, RadiantGraph launched Care Guidance Agents to change that: AI voice agents that call Medicare patients between visits with coaching, adherence reminders, and preventive care prompts.

Updated Sep 17

The blood test revolution in Alzheimer's diagnosis

New Capabilities

Covers tests only after symptoms appear; ASAP Act pending

Alzheimer's diagnosis used to require a $5,000 brain scan or a painful spinal tap. As of August 2026, the FDA has cleared four blood tests for the disease, from Roche's Elecsys pTau217 to C2N's PrecivityAD2, approved for adults as young as 40.

Updated Aug 25

CMS and FDA launch RAPID pathway for breakthrough device coverage

Rule Changes

Issuing proposed procedural notice; TCET pathway paused for new candidates

For nearly a decade, medical device makers have faced the same bottleneck: the FDA clears a breakthrough device, and then Medicare spends another year or more deciding whether to pay for it. On April 23, 2026, the two agencies jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway — it cuts that timeline to as little as two months. They simultaneously paused the existing Transitional Coverage for Emerging Technologies (TCET) program for new applicants, consolidating all breakthrough-device coverage work under RAPID.

Updated May 31

U.S. health care spending growth hits its slowest stretch since tracking began in 1960

Rule Changes

Source of baseline spending projections and historical data

For decades, American health care spending grew faster than the economy. Government actuaries projected in 2010 that it would hit 21.2 percent of GDP by 2024 (about $6.3 trillion), but actual spending came in at 18%, roughly $977 billion less.

Updated May 31

The battle to put GLP-1 drugs on Medicare

Rule Changes

Administering BALANCE model to expand GLP-1 access

Medicare has been banned from covering weight loss drugs since 2003. CMS launched BALANCE in December 2025, a voluntary model offering $50-per-month Ozempic and Wegovy access for 10% of Medicare enrollees starting July 2026.

Updated May 16

Trump orders a fast-track marijuana reschedule to Schedule III—reviving a stalled Biden-era process

Rule Changes

Linked to a new CBD access pilot described alongside the executive order

Trump's executive order instructing DOJ to fast-track marijuana's move to Schedule III immediately triggered a familiar split. Public health and industry groups cheered the potential research and tax impacts, while House Republicans organized opposition, urging Trump to keep marijuana in Schedule I.

Updated May 15